Skip to content
Logo
  • Home
  • FeNO
    • What is FeNO?
    • FeNO in asthma
    • Benefits of FeNO use
    • Measuring FeNO with the NObreath®
  • NObreath®
    • What is the NObreath®?
    • Already own a NObreath®
    • How to use the NObreath®
    • Consumables
    • Literature
  • News
  • Medical Advisory Board
  • Software
  • Support
    • Educational Portal
    • FAQs
    • Literature
  • Contact
  • English
    • English
    • United States

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

Bedfont® outlines key updates and offers support for healthcare professionals navigating the changes. Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and... read more →

Children with Asthma: Webinar led by Carol Stonham MBE and Medway Asthma Self-Help, providing key information on managing asthma in children

Bedfont® Scientific Limited hosted an informative webinar Children with Asthma, with seasoned respiratory nurse Carol Stonham MBE leading the discussion along with Kirsty at Medway Asthma Self-Help (MASH). The webinar... read more →

World Lung Day 2024: Clean Air and Healthy Lungs for All

World Lung Day was created in 2017 by the Forum of International Respiratory Societies (FIRS), the day was established to raise awareness about lung health and advocate for better lung... read more →

The NObreath® Utilising the TrueFlo™ Technology in FeNO Testing

Methods of measuring FeNO Fractional exhaled Nitric Oxide (FeNO) measurement plays a crucial role in the diagnosis and management of airway inflammation. FeNO testing is recommended in the joint guidelines from the National Institute for Health and... read more →
Bedfont expands accessibility to FeNO testing

Bedfont® are thrilled to announce a new partnership with Geratherm® Group

A door opens to ensure the gold standard of FeNO testing is available in Latin America. Bedfont® Scientific Limited, world leaders in breath analysis, with over 47 years of experience... read more →

Addressing Primary Care Challenges with the NObreath®

FeNO Testing in As Although airway eosinophilic inflathma Caremmation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring... read more →

FeNO Devices– Considerations when Investing

Like any healthcare investment, consideration needs to be given when deciding which fractional exhaled nitric oxide (FeNO) device might best suit the clinical area in which it will be used.... read more →

Love Your Lungs Week 2024: How the NObreath® aids in the diagnosis and management of asthma

To mark Love Your Lungs Week, Bedfont® Scientific Ltd. raises awareness of FeNO testing in asthma care. Love Your Lungs Week is an annual event which takes place from 21st... read more →

Unlocking Better Breathing: Asthma Awareness for Love Your Lungs Week 2024

Love Your Lungs Week is a national awareness event which occurs annually in June, taking place from 21st June to 27th June 2024. Initiated by the British Lung Foundation, now... read more →

Electrochemical Sensor Technology: The new gold standard for FeNO testing

A history of Fractional exhaled Nitric Oxide (FeNO) testing: where it all began The story of FeNO began in the 1990s after it gained a lot of interest from researchers... read more →
  • 1
  • 2
  • 3
  • 4
  • 5

« Previous Page — Next Page »

Contact Details

Bedfont® Scientific Ltd
Station Road, Harrietsham, Maidstone
Kent, ME17 1JA, England

Tel: +44(0)1622 851122
Email: ask@bedfont.com

Products

NObreath®

Smokerlyzer®

Gastrolyzer®

ToxCO®

Medi-Gas Check

Accreditations

ISO 13485:2016

Bedfont EC REP - Emergo

Useful Links

What is FeNO?

FeNOchart™

What is the NObreath®?

Resources

FAQs

Contact Us


References



White Bedfont text logo

© 1976-2026 Bedfont® Scientific Ltd., all rights reserved | Incorporated in England and Wales under registered number: 1289798

Legal Stuff | Privacy Notice | Help Centre